Status:
RECRUITING
Artificial Intelligence for Preventing Heart Disease (AiPHD): Observational, Single Center, Prospective and Retrospective Study
Lead Sponsor:
IRCCS San Raffaele
Collaborating Sponsors:
DGS
EBIT
Conditions:
Coronary Artery Disease
Eligibility:
All Genders
18+ years
Brief Summary
Coronary artery disease (CAD) is a leading cause of mortality in western countries. Coronary computed tomography angiography (cCTA) is the first-line imaging test in patients with suspected obstructiv...
Detailed Description
Background and Rationale In recent years, cCTA has become a crucial diagnostic tool for suspected CAD, recommended as the first-line test for patients with an intermediate pre-test probability of CAD...
Eligibility Criteria
Inclusion
- Patients with cCTA performed for CAD assessment
Exclusion
- Refusal to participate in the study
- Age \<18 years old
- Presence of other cardiovascular comorbidities (e.g. severe valvulopathies; non-ischemic cardiomyopathies; etc.)
Key Trial Info
Start Date :
July 31 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2028
Estimated Enrollment :
3000 Patients enrolled
Trial Details
Trial ID
NCT06029387
Start Date
July 31 2023
End Date
March 1 2028
Last Update
May 1 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
IRCCS San Raffaele
Milan, Italy, 20132